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Two new angucyclic quinones, angumycinones A (1) and B (2) and six known angucyclinone analogues
(3–8) were isolated from a liquid culture extract of the Streptomyces sp. KMC004 strain from acidic coal
mine drainage. The structures of these compounds were established using extensive spectroscopic data
analyses, including NMR, HRFABMS, UV, CD, and X-ray crystallography. Compounds 1–8 were tested for
antimicrobial activity against ten pathogenic microbial or fungal strains. Angumycinone B (2) exhibited
antimicrobial activity against Micrococcus luteus, Enterococcus hirae, and methicillin-resistant Staphylo-
coccus aureus (MRSA) with minimum inhibitory concentration values of 0.78, 1.56, and 12.5 lg/mL,
respectively.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Microorganisms are a fertile resource for natural product-based
drug discovery programs. In particular, terrestrial soil-derived
Streptomyces species have been extensively studied because they
can potentially provide pharmaceutical candidates; approximately
70% of clinically useful antibiotics are derived from natural
sources.1 However, the chemical redundancy of products isolated
from these bacteria has become one of the current challenges in
the discovery of novel natural product-derived drug candidates.2
One approach to overcome this problem is to utilize Streptomyces
species derived from unique habitats, such as marine environ-
ments,3 mutualistic associations with hosts,4 etc.; these strains
have been exploited to provide novel microbial chemotypes over
the last few years. Many recent investigations have uncovered
compelling evidence that the Streptomyces species derived from
unique environmental samples might lead to the discovery of sec-
ondary metabolites with signiﬁcant biological activity.5
Acidic mine drainage is generated by the oxidative reactions
that result from the exposure of sulﬁde minerals, such as iron
pyrite or iron disulﬁde, to the atmosphere. Acidic mine drainage
is a geochemically extreme environment,6 and the acidic water
system provides ecologically unique habitats for the growth andmetabolism of diverse microbes.7 Under harsh environmental con-
ditions, such as acidic mine drainage, microorganisms may face
ecological competition, driving their metabolic potential and
requiring the biosynthesis of new secondary metabolites.8
The Streptomyces sp. KMC004 strain was isolated from an acidic
mine drainage sample (209 ppm Fe, 6.7 ppm Mn, 0.8 ppm Pb, and
0.8 ppm Cu; pH 3.0) collected from the Young-dong abandoned
coal mine located at Gangneung, South Korea, during our ongoing
investigation of novel secondary metabolites from microorganisms
collected from unique environments. The strain was most likely a
Streptomyces sp. based on the 98.3% 16S rRNA sequence similarity
with the Streptomyces chryseus strain (EU841613). The Streptomy-
ces sp. KMC004 strain was cultivated in YM liquid medium (5 g
of yeast and 30 g of malt in 1 L of distilled water) for 10 days at
25 C. The initial high-performance liquid chromatography mass
spectrometry (HPLC/MS) analyses of the liquid cultured KMC004
revealed six major constituents with characteristic quinone-like
ultraviolet (UV) chromophores.9 To identify their molecular struc-
tures, the whole culture broth (8 L) was extracted with ethyl ace-
tate (16 L), and the extracts (1.2 g) were subjected to gradient
reverse-phase chromatography. The six major metabolites were
identiﬁed as known angucyclinone structures [MM 47755 (3),10
(+)-rubiginone B2 (4),11 (+)-ochromycinone (5),12 (+)-hatomarubi-
gin A (6),13 (+)-rubiginone D2 (7),14 and X-14881 E (8)15 by
comparing their spectroscopic data with previously reported spec-
troscopic data (Fig. 1). Angucyclinones are characterized with an
angular tetracyclic (benz[a]anthracene) carbon skeleton and are
one of the many aromatic polyketides predominantly isolated from
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Figure 1. Structures of compounds 1–8.
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angucyclinone analogues have exhibited a broad range of biologi-
cal properties, including cytotoxicity,17 antibacterial,18 and platelet
aggregation inhibition properties.19 To date, angucyclic quinones
are continuously growing more attractive as a class of natural
products due to their structural diversity, biomedical potential,
and well-deﬁned biosynthetic pathways.16,20 Therefore, we inves-
tigated the liquid culture media of KMC004 further to discover
novel angucyclic quinones. Consequently, two highly oxygenated
angucyclic quinones (Fig. 1) were isolated as minor constituents
(1: 8 mg and 2: 5 mg) from ethyl acetate extracts (1.2 g) of Strepto-
myces sp. KMC004 strain and named angumycinones A (1) and B
(2). Herein, we describe the isolation, structure elucidation, and
antimicrobial activities of 1 and 2.
Angumycinone A (1)21 was obtained as colorless block crystal
with an assigned molecular formula of C19H16O6 based on our high
resolution fast-atom bombardment mass spectrometry
(HRFABMS) data (obsd [M+H]+ m/z 341.1025, calcd 341.1025).
The infrared (IR) spectrum of 1 displayed intense absorption bands
at 3427 and 1640 cm1, suggesting the presence of hydroxyl and
carbonyl groups, respectively. The UV spectrum of 1 revealed a qui-
none-like chromophore.9 The 1H NMR spectrum was recorded in
pyridine-d5 and displayed signals for three aromatic methines (dH
7.54, 7.43, and 7.21), a vinyl methine (dH 5.95), a methine (dH
4.56), three methylene groups [(dH 3.03, 2.49), (dH 3.00, 2.46),
and (dH 1.84, 1.58)], a methyl (dH 1.76), and two exchangeable
protons (dH 11.63 and 7.03). The 13C NMR spectrum revealed 19
signals, including three aromatic methine carbons (dC 136.8,
123.5, and 119.6), one vinyl methine carbon (dC 125.5), three aro-
matic quaternary carbons (dC 161.1, 133.6, and 115.4), a vinyl qua-
ternary carbon (dC 159.6), three carbonyl carbons (dC 197.9, 194.8,
and 192.2), three oxygenated quaternary carbons (dC 68.7, 66.1,
and 64.4), three methylene carbons (dC 46.2, 27.2, and 18.1), one
methine carbon (dC 49.9), and a methyl carbon (dC 24.0). Analyses
of the 1H and 13C NMR spectral data indicated that the compounds
had characteristics of the tetracyclic benz[a]anthracene class,
referring to an angularly constructed framework composed of four
conjugated ring systems (rings A–D) (Table 1).16 Analyses of the
extensive 2D NMR spectral data led to the identiﬁcation of the pla-
nar structure of compound 1 (Fig. 2). The COSY correlations from
both H-11 at dH 7.54 and H-9 at dH 7.21 (dd, J = 8.5, 1.5 Hz) to
H-10 (dH 7.43, dd, J = 8.5, 7.5 Hz) suggested the presence of
1,2,3-trisubstituted benzene ring (D-ring). The aromatic methine
H-10 (dH 7.43) exhibited a HMBC correlation to the oxygenated
aromatic quaternary carbon C-8 (dC 161.1), and the phenolic OH
signal attached at C-8 displayed a downﬁeld shifted proton reso-
nance (dH 11.63) due to intramolecular hydrogen-bonding with
the adjacent carbonyl C-7 (dC 197.9).22 An additional COSY correla-
tion between two methylene groups [H2-5 (dH 1.84 and 1.58) andH2-6 (dH 3.00 and 2.46)], coupled with HMBC correlations from
methylene H2-6 to C-4a (dC 68.7), C-6a (dC 66.1), and C-12a (dC
64.4), and from another methylene H2-5 to C-4a (dC 68.7) and
C-6a (dC 66.1), allowed us to construct the B-ring and assign its
substituted pattern (Fig. 1). In addition, the construction of the
A-ring was established with the HMBC correlations from the vinyl
methine H-2 (dH 5.95) to C-4 (dC 46.2) and from a methyl singlet
(dH 1.76) to C-2 (dC 125.5) and C-3 (dC 159.6), indicating the pres-
ence of a methyl-substituted double bond.23 The connectivity of
the A- and B-rings was achieved based on the HMBC correlations
from H-2, H-4, and H2-5 to C-12b (dC 49.9) and from H-4 to C-5
(dC 27.2). Finally, the planar structure of 1 was determined using
the HMBC correlations from H-11 and H-12b to C-12 (dC 192.2),
in addition to the weak HMBC correlation between H-11 and C-7
(dC 197.9), suggesting that the C-ring was quinone-like. The exis-
tence of an epoxide between C-6a (dC 66.1) and C-12a (dC 64.4)
was deduced by comparing the 13C chemical shifts with the spectra
data of previously reported compounds.24
The relative conﬁguration of H-12b was initially determined by
interpreting the 2D NOESY NMR spectral data and long range cor-
relation between H-12b and H-5b in the 1H–1H COSY spectrum of
1. The strong NOE correlation between the methine H-12b and
H-4b indicated that these two protons were axially placed on the
same side. The methane H-12b demonstrated a 1H–1H COSY corre-
lation with H-5b, indicating the W-shape arrangement of the
connecting bonds between H-12b and H-5b. This alignment was
also supported by long range coupling (4J12b,5b = 2.0 Hz) between
H-12b and H-5b proton signals in the 1H NMR spectrum of 1.25
These data allowed us to assign the relative conﬁguration of
H-12b and H-5b to be cis-conﬁguration. The absolute conﬁguration
of 1 was deduced with a direct method to be 4aR, 6aS, 12aR, and
12bR via single crystal X-ray diffraction analyses conducted with
Mo Ka radiation, resulting in a reﬁned Flack parameter value of
1.2(9) using 1553 Friedel pairs (Fig. 3).26
Angumycinone B (2)27 was obtained as pale yellowish oil. An
HRFABMS analysis indicated that the molecular formula of 2 was
C19H16O7 (obsd [M+H]+ m/z 357. 0980, calcd 357.0974). The 1H
and 13C NMR spectral data of 2 were very similar to that of 1;
the major differences between the two data sets were signals indi-
cating the presence of the additional hydroxyl group (dH 8.10) and
an oxygenated methine (dH 5.23, dC 62.7),28 suggesting that 2was a
6-hydroxy analogue of 1. The attachment of the hydroxyl group at
C-6 in 2 was conﬁrmed by the COSY correlations of both H2-5 (dH
2.08 and 1.93) and 6-OH (dH 8.10) with H-6 (dH 5.23) and the HMBC
correlation from H2-5 to C-6 (dC 62.7). The relative and absolute
conﬁgurations of 2 were assigned by analyzing the NOESY correla-
tions together with CD spectral data. The CD and NOESY spectra of
2 were very similar to that of 1. The broad singlet signal of H-6 in
the 1H NMR spectrum of 2 and the key NOESY correlations of both
axial H-5a and equatorial H-5b with H-6 suggested that the 6-OH
was placed axially in the b-orientation, while H-6 was in an a-
equatorial conﬁguration. In addition, the methane H-12b demon-
strated a long range correlation (4J12b,5b = 2.3 Hz) with H-5b in
the 1H–1H COSY and 1H NMR spectra of 2, indicating W-shape
connection and cis-conﬁguration of H-12b and H-5b. The absolute
conﬁguration of 2 was determined to be 4aS, 6R, 6aS, 12aR, and
12bR and was validated with the very similar CD spectra of 2
and 1 (Fig. 4).
The angumycinones (1 and 2) represent highly oxygenated
angucyclic quinones; this scaffold is characterized by the presence
of an epoxide group situated between C-6a and C-12a. Only nine
natural 6a,12a-epoxybenz[a]anthracene derivatives have been re-
ported so far from soil-based Streptomyces species.9,14,23,24,28,29 Of
these nine structures, angumycinone A (1) is the most similar in
structure to grecocycline A aglycon, which features a hydroxyl
group positioned at C-12b. One critical difference in structure
Table 1
1H and 13C NMR spectral data for compounds 1 and 2 in pyridine-d5 (dH 8.69, dC 149.9)
Compound 1 Compound 2
Position dH mult (J, Hz)a dCb dH mult (J, Hz)a dCb
1 194.8 C 194.6 C
2 5.95 s 125.5 CH 5.93 dd (2.0, 1.0) 125.6 CH
3 159.6 C 159.7 C
3-CH3 1.76 br s 24.0 CH3 1.75 br s 24.0 CH3
4b 3.03c 46.2 CH2 2.91 ddd (18.0, 2.5, 1.0) 45.7 CH2
4a 2.49 d (17.0) 2.47 d (18.0)
4a 68.7 C 71.1 C
5a 1.84 ddd (18.0, 13.0, 5.0) 27.2 CH2 2.08 dd (14.5, 3.5) 34.8 CH2
5b 1.58 m 1.93 ddd (14.5, 2.5, 2.3)
6b 3.00c 18.1 CH2
6a 2.46 dd (13.0, 5.0) 5.23 br s 62.7 CH
6a 66.1 C 66.4 C
7 197.9 C 196.3 C
7a 115.4 C 115.3 C
8 161.1 C 162.0 C
9 7.21 dd (8.5, 1.5) 123.5 CH 7.22 dd (8.5, 1.0) 124.2 CH
10 7.43 dd (8.5, 7.5) 136.8 CH 7.45 dd (8.5, 7.5) 137.3 CH
11 7.54c 119.6 CH 7.56 dd (7.5, 1.0) 120.0 CH
11a 133.6 C 133.0 C
12 192.2 C 191.0 C
12a 64.4 C 64.7 C
12b 4.56 d (2.0) 49.9 CH 4.66 d (2.3) 51.1 CH
4a-OH 7.03 7.43
6-OH 8.10
8-OH 11.63 11.95
a Assignment by 1H NMR experiments performed at 500 MHz.
b Assignment by 13C NMR experiments performed at 125 MHz.
c The coupling constants cannot be assigned due to signal overlap.
Figure 2. Key COSY and HMBC correlations of compounds 1 and 2.
Figure 3. X-ray Oak Ridge Thermal Ellipsoid Plot (ORTEP) drawing of compound 1.
Figure 4. CD spectra of compounds 1 (---) and 2 (—).
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tions of the stereocenters at C-12b and C-4a. A hydroxyl group at
C-6, similar to the one in angumycinone B (2), can also be observed
in simocyclinone D4 aglycon, which contains additional hydroxyl
groups at C-12b and C-7. However, the absolute conﬁguration ofthese molecules has never been reported. Therefore, this Letter is
the ﬁrst report establishing the absolute conﬁgurations of angucy-
clic quinone structures via single-crystal X-ray diffraction analyses.
Compounds 1–8 were tested for their antimicrobial activity
against four Gram-positive bacteria, including Micrococcus luteus
KCCM1548, Enterococcus hirae KCCM11768, Bacillus subtilis
KCTC1021, and Staphylococcus aureus CCARM3089 (MRSA), in addi-
tion to three Gram-negative bacteria (Salmonella typhimurium
KCCM11862, Klebsiella pneumonia KCCM35454, and Escherichia coli
KCTC2593) and three fungal strains (Aspergillus fumigatus HIC6094,
Trichophyton rubrum KCCM60443, and Candida albicans
KCCM11282) using previously described minimum inhibitory con-
centration (MIC) assay method.30 Ampicillin and amphotericin B
were used as positive controls for pathogenic bacteria and fungi,
respectively. Ampicillin exhibited antimicrobial activities against
M. luteus, E. hirae, B. subtilis, MRSA, S. typhimurium, K. pneumonia,
and E. coli with MIC values of 0.78, 0.78, 3.13, 12.5, 12.5, 12.5,
and 6.25 lg/mL, respectively. The MIC values of amphotericin B
were 1.56 lg/mL against each fungal strain (A. fumigatus, T. rubrum,
66 H. B. Park et al. / Tetrahedron Letters 55 (2014) 63–66and C. albicans). Angumycinone A (1) exhibited moderate antimi-
crobial activities against M. luteus and E. hirae (MIC values of
6.25 and 12.5 lg/mL, respectively); however, angumycinone B (2)
was more active than 1 against the same strains (0.78 and
1.56 lg/mL, respectively). In addition, 2 demonstrated moderate
activity against methicillin-resistant S. aureus (MRSA), displaying
a MIC value of 12.5 lg/mL. The three known angucyclinone ana-
logues, 3, 5, and 8, also exhibited antimicrobial activity against
M. luteus and E. hirae, while the other compounds (4, 6, and 7) were
not active against any of the tested strains. MIC values of both
compounds 3 and 5 were 0.39 and 0.78 lg/mL against M. luteus
and E. hirae, respectively, while 8 displayed 0.39 lg/mL MIC value
against both pathogenic bacteria. None of the compounds demon-
strated any antimicrobial activity against the Gram-negative
bacterial or fungal strains.
Acknowledgment
This work was supported by the Korea Institute of Science and
Technology institutional program, Grant numbers 2Z03840.
Supplementary data
Supplementary data (experimental methods, X-ray data, NMR,
HRFABMS and IR spectra of new compounds) associated with this
article can be found, in the online version, at http://dx.doi.org/
10.1016/j.tetlet.2013.10.112.
References and notes
1. Bérdy, J. J. Antibiot. 2005, 58, 1–26.
2. Lam, K. S. Curr. Opin. Microbiol. 2006, 9, 245–251.
3. (a) Dharmaraj, S. World. J. Microbiol. Biotechnol. 2010, 26, 2123–2139; (b) Bull,
A. T.; Stach, J. E. M. Trends Microbiol. 2007, 15, 491–499; (c) Fenical, W.; Jensen,
P. R. Nat. Chem. Biol. 2006, 2, 666–673.
4. (a) Currie, C. R.; Scott, J. A.; Summerbell, R. C.; Malloch, D. Nature 1999, 398,
701–704; (b) Crawford, J. M.; Clardy, J. Chem. Commun. 2011, 7559–7566.
5. (a) Takagi, M.; Shin-ya, K. J. Antibiot. 2012, 65, 443–447; (b) Olano, C.; Méndez,
C.; Salas, J. A.Mar. Drugs 2009, 7, 210–248; (c) Oh, D.-C.; Scott, J. J.; Currie, C. R.;
Clardy, J. Org. Lett. 2009, 11, 633–636; (d) Header, S.; Wirth, R.; Herz, H.;
Spiteller, D. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 4742–4746; (e) Kroiss, J.;
Kaltenpoth, M.; Schneider, B.; Schwinger, M.-G.; Hertweck, C.; Maddula, R. K.;
Strohm, E.; Svatoš, A. Nat. Chem. Biol. 2010, 6, 261–263.
6. Johnson, D. B.; Hallberg, K. B. Sci. Total Environ. 2005, 338, 3–14.7. (a) Johnson, D. B. FEMS Microbiol. Ecol. 1998, 27, 307–317; (b) Xie, J.; He, Z.; Liu,
X.; Van Nostrand, J. D.; Deng, Y.; Wu, L.; Zhou, J.; Qiu, G. Appl. Environ. Microbiol.
2011, 77, 991–999.
8. (a) Park, H. B.; Kwon, H. C.; Lee, C.-H.; Yang, H. O. J. Nat. Prod. 2009, 72, 248–
252; (b) Park, H. B.; Kim, Y.-J.; Park, J.-S.; Yang, H. O.; Lee, K. R.; Kwon, H. C. J.
Nat. Prod. 2011, 74, 2309–2312; (c) Park, H. B.; Kim, Y.-J.; Lee, J. K.; Lee, K. R.;
Kwon, H. C. Org. Lett. 2012, 14, 5002–5005.
9. Paululat, T.; Kulik, A.; Hausmann, H.; Karagouni, A. D.; Zinecker, H.; Imhoff, J. F.;
Fiedler, H.-P. Eur. J. Org. Chem. 2010, 2344–2350.
10. Gilpin, M. L.; Balchin, J.; Box, S. J.; Tyler, J. W. J. Antibiot. 1989, 42, 627–628.
11. Oka, M.; Kamei, H.; Hamagishi, Y.; Tomita, K.; Miyaki, T.; Konishi, M.; Oki, T. J.
Antibiot. 1990, 43, 967–976.
12. Kaliappan, K. P.; Ravikumar, V. J. Org. Chem. 2007, 72, 6116–6126.
13. Hayakawa, Y.; Ha, S.-C.; Kim, Y. J.; Furihata, K.; Seto, H. J. Antibiot. 1991, 44,
1179–1186.
14. Puder, C.; Zeeck, A. J. Antibiot. 2000, 53, 329–336.
15. Parker, K. A.; Ding, Q.-J. Tetrahedron 2000, 56, 10249–10254.
16. Rohr, J.; Thiericke, R. Nat. Prod. Rep. 1992, 9, 103–137.
17. Xie, Z.; Liu, B.; Wang, H.; Yang, S.; Zhang, H.; Wang, Y.; Ji, N.; Qin, S.; Laatsch, H.
Mar. Drugs 2012, 10, 551–558.
18. Bruntner, C.; Binder, T.; Pathom-aree, W.; Goodfellow, M.; Bull, A. T.; Potterat,
O.; Puder, C.; Hörer, S.; Schmid, A.; Bolek, W.; Wagner, K.; Mihm, G.; Fiedler, H.-
P. J. Antibiot. 2005, 58, 346–349.
19. Omura, S.; Nakagawa, A.; Fukamachi, N.; Miura, S.; Takahashi, Y.; Komiyama,
K.; Kobayashi, B. J. Antibiot. 1988, 41, 812–813.
20. (a) Palmu, K.; Ishida, K.; Mäntsälä, P.; Hertweck, C.; Metsä-Ketelä, M.
ChemBioChem 2007, 8, 1577–1584; (b) Kallio, P.; Liu, Z.; Mäntsälä, P.; Niemi,
J.; Metsä-Ketelä, M. Chem. Biol. 2008, 15, 157–166.
21. Angumycinone A (1): colorless block crystal; mp 180–182 C; ½a25D +112.0 (c
0.10, CH3CN); CD (CH3CN) kmax (De) 370 (1.66), 325 (+0.96), 284 (+0.47), 231
(+3.03) nm; UV (CH3CN) kmax (loge) 360 (3.43), 236 (4.17), 204 (4.05) nm; IR
(ﬁlm) mmax 3427, 1640, 1452, 1276, 969 cm1; 1H and 13C NMR spectra, see
Table 1; HRFABMS [M+H]+ m/z 341.1025 (calcd for C19H17O6, 341.1025).
22. Taniguchi, M.; Nagai, K.; Watanabe, M.; Niimura, N.; Suzuki, K.; Tanaka, A. J.
Antibiot. 2002, 55, 30–35.
23. Sasaki, T.; Gomi, S.; Sezaki, M.; Takeuchi, Y.; Kodama, Y.; Kawamura, K. J.
Antibiot. 1988, 41, 843–848.
24. Fotso, S.; Mahmud, T.; Zabriskie, T. M.; Santosa, D. A.; Sulastri; Proteau, P. J. J.
Nat. Prod. 2008, 71, 61–65.
25. Balci, M. Basic 1H and 13C NMR spectroscopy; Elsevier: Amsterdam, 2005; pp
130–132.
26. Flack, H. D. Acta Crystallogr., Sect. A 1983, 39, 876–881.
27. Angumycinone B (2): pale yellowish oil; ½a25D +115.2 (c 0.10, CH3CN); CD
(CH3CN) kmax (De) 370 (1.31), 325 (+0.41), 283 (+0.84), 246 (+3.00) nm; UV
(CH3CN) kmax (loge) 361 (3.45), 236 (4.19), 204 (4.04) nm; IR (ﬁlm) mmax 3417,
1651, 1455, 1267, 1088 cm1; 1H and 13C NMR spectra, see Table 1 ; HRFABMS
[M+H]+ m/z 357.0980 (calcd for C19H17O7, 357.0974).
28. Holzenkämpfer, M.; Walker, M.; Zeeck, A. J. Antibiot. 2002, 55, 301–307.
29. (a) Sun, C.-H.; Wang, Y.; Wang, Z.; Zhou, J.-Q.; Jin, W.-Z.; You, X.-F.; Gao, H.;
Zhao, L.-X.; Si, S.-Y.; Li, X. J. Antibiot. 2007, 60, 211–215; (b) Tsukuda, E.; Tanaka,
T.; Ochiai, K.; Kondo, H.; Yoshida, M.; Agatsuma, T.; Saitoh, Y.; Teshiba, S.;
Matsuda, Y. J. Antibiot. 1996, 49, 333–339.
30. Park, H. B.; Yang, H. O.; Lee, K. R.; Kwon, H. C. Molecules 2011, 16, 3519–3529.
